For instance, CB1 activation offer protection in various neurodegenerative diseases, including Alzheimer’s disease [37, 38, 56], Parkinson’s disease [30, 46], and HD [39, 41]. Here, CNR1 is linked to early-onset autosomal dominant Alzheimer disease.